Morgan Stanley Maintains a Sell Rating on Walgreens Boots Alliance (WBA)

Morgan Stanley analyst Ricky Goldwasser maintained a Sell rating on Walgreens Boots Alliance (WBAResearch Report) today and set a price target of $43.00. The company’s shares closed last Monday at $43.32.

According to TipRanks.com, Goldwasser is a 5-star analyst with an average return of 12.6% and a 62.2% success rate. Goldwasser covers the Healthcare sector, focusing on stocks such as Lifestance Health Group, Alignment Healthcare, and AmerisourceBergen.

The word on The Street in general, suggests a Hold analyst consensus rating for Walgreens Boots Alliance with a $48.20 average price target.

See today’s best-performing stocks on TipRanks >>

Walgreens Boots Alliance’s market cap is currently $37.26B and has a P/E ratio of 5.95.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Retail pharmacy leader Walgreens Boots Alliance (NASDAQ:WBA) operates through its namesake brand Walgreens in the U.S. and Boots in the U.K. In addition, it owns retail and business brands including the No7 Beauty Company, Duane Reade, Ahumada in Chile, and Benavides in Mexico. The company also targets equity investments in healthcare, pharmacy, and retail and has a presence in over 25 countries with more than 450,000 employees.

Read More on WBA:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More

Latest News Feed